Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ALS
Pharma
Amylyx to pull failed ALS drug from market, cut 70% of staff
Amylyx is pulling the ALS drug Relyvrio from the U.S. and Canadian markets after a confirmatory trial failure.
Angus Liu
Apr 4, 2024 10:06am
Amylyx's ALS drug finally scores a positive vote from FDA panel
Sep 8, 2022 8:16am
Amylyx's ALS drug faces tough FDA scrutiny—again
Sep 6, 2022 4:38pm
ALS Association pushes for FDA approval of pending Amylyx drug
Sep 15, 2021 11:11am
New Alzheimer's drug gives price reformers their poster child
Jun 10, 2021 10:29am
JPM: Alexion to take next-gen Ultomiris into tough ALS study
Jan 14, 2020 5:00pm
